ARCHIVES

NCI Implements Changes To Speed Up New Drug Development; compounds In Pipeline Listed

This article is from The Cancer Letter archive.

Vol. 02 No. 28 | July 9, 1976

Download PDF Visit The Full Archive

Related Articles

NSABP Objects to “Closed Process” For Review Of P-4 Breast Cancer Chemoprevention Trial.

April 20, 2007

Oblimersen Combination Improves CLL Survival

December 28, 2007

December Business & Regulatory Report included in this issue.

December 12, 2003

Lilly Begins Phase III Trial Of Alimta In Extensive SCLC

October 27, 2006

NIH Probing: Double Dipping” Allegation

September 4, 1981

Young Scientists Get Their Share Of NCI Grants

March 29, 1974